Home
CANDLE
Conceptualize and support the establishment of a European network of National Cancer Data Nodes
CANDLE (national CAncer data Node DeveLopErs) aims to improve the (re)use of cancer data by supporting the establishment National Cancer Data Nodes (NCDNs) in European Member States and associated countries (e.g. Norway and Switzerland). Together, these NCDNs will form the UNCAN.eu network that will support the European Initiative to Understand Cancer (UNCAN.eu, a federated European cancer research data infrastructure) and the European Cancer Patient Digital Centre (ECPDC, a European network of national digital infrastructures for cancer patients).
40
Partners
3M €
Funding
3
Years
About CANDLE
Data is an essential resource to improve our understanding of cancer, advance prevention and early detection strategies, facilitate the delivery of personalised care, and better address the quality of life of cancer patients and survivors.
CANDLE (national CAncer data Node DeveLopErs) aims to improve the (re)use of cancer data by supporting the establishment of National Cancer Data Nodes (NCDNs) in European Member States and associated countries (e.g. Norway and Switzerland). A staged approach will be taken by first conceptualizing the NCDNs based on the user needs. As NCDNs should build on existing national structures, there is no one-size-fits-all solution, so CANDLE will develop a maturation model for countries to assess their current status. Based on this status, an implementation roadmap can be provided including alignment with relevant cancer domain efforts and the European Health Data Space (EHDS). All tools to support the establishment of an NCDN will be collected in the CANDLE resource kit.
Together, these NCDNs will form the UNCAN.eu network that will support the European Initiative to Understand Cancer (UNCAN.eu, a federated European cancer research data infrastructure) and the European Cancer Patient Digital Centre (ECPDC, a European network of national digital infrastructures for cancer patients).
CANDLE is a European consortium funded by the European Health and Digital Executive Agency (HaDEA) including representation from 20 different countries and European research infrastructures.
Lygature in CANDLE
Lygature supports CANDLE with over-all partnership management, including coordination of engagement between the consortium and national representatives. In this role, Lygature can benefit from extensive experience in previous multi-stakeholder collaborations on the European (e.g. Bigpicture) and national level (e.g. Health-RI).
Next to partnership management, Lygature will contribute specific data infrastructure expertise relevant to creating a European network of National Cancer Data Nodes that act in a complementary way to existing European research infrastructures, regulations (e.g. European Health Data Space) and cancer domain initiatives (e.g. EUCAIM).
Partners
HEALTH-RI; EUROPEAN MOLECULAR BIOLOGY LABORATORY (ELIXIR); BARCELONA SUPERCOMPUTING CENTRE; STEINBEIS INNOVATION GGMBH; CHARITE - UNIVERSITAETSMEDIZIN BERLIN; EMPIRICA; FINNISH CANCER CENTER FICAN; BBMRI-ERIC; MASARYKUV ONKOLOGICKY USTAV; EATRIS ERIC; UNIVERZITA PALACKEHO V OLOMOUCI; ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK; EURO-BIOIMAGING ERIC; CONSIGLIO NAZIONALE DELLE RICERCHE; UNIVERSITY UTRECHT; STICHTING INTEGRAAL KANKERCENTRUM NEDERLAND; EUROPEAN CANCER ORGANIZATION; FUNDACIO CENTRE DE REGULACIO GENOMICA; CANCER RESEARCH AND INNOVATION HUB MALTA; INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD; KAUNO TECHNOLOGIJOS UNIVERSITETAS; LUXEMBOURG INSTITUTE OF HEALTH; SCIENSANO; ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS; ETHNIKO KENTRO TEKMIRIOSIS KAI ILEKTRONIKOU PERIECHOMENOU; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; OSLO UNIVERSITETSSYKEHUS HF; UNIVERSITY OF LIMERICK; FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA; ASSOCIACAO ISCTE CONHECIMENTO E INOVACAO - CENTRO DE VALORIZACAO E TRANSFERENCIA DE TECNOLOGIA; SWISS INSTITUTE OF BIOINFORMATICS; SOCIALSTYRELSEN; KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA; KARAISKAKEIO IDRYMA; UPPSALA UNIVERSITET; INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK; UNIVERZA V LJUBLJANI; MEDIZINISCHE UNIVERSITAET WIEN; REGION NORDJYLLAND